FTC sues main pharmacy gain managers over insulin prices The agency introduced motion from Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the list price of existence-saving insulin medication. UnitedHealth sues CMS around Medicare Advantage star rankings A few options owned with the https://griffinhdxto.blogdosaga.com/30578308/the-healthcare-news-diaries